India initiates anti-dumping investigation on ciprofloxacin hydrochloride in China

Source: China Trade Remedy Information Network Time: 2020-01-10

On January 10, 2020, the Ministry of Commerce and Industry of India issued an announcement saying that in response to an application submitted by Indian domestic company Aarti Drugs Limited, an anti-dumping investigation was initiated against Ciprofloxacin Hydrochloride, which was originated from or imported from China. The case mainly involved products under Indian Customs Code 29419030. The dumping investigation period of this case is from April 1, 2018 to June 30, 2019 (15 months), and the damage investigation period is from April 2015 to March 2016, April 2016 to March 2017, 2017 April to March 2018 and the dumping investigation period.